Bioequivalence Study of 200 mg Lamotrigine Tablet Under Fasting Conditions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 32
- Registration Number
- NCT00834561
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Non-Fasting
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2009-09-15
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 40
- Registration Number
- NCT00834587
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
🇺🇸PRACS Institute Ltd., East Grand Forks, Minnesota, United States
5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Fasting
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2009-09-15
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 40
- Registration Number
- NCT00835497
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
🇺🇸PRACS Institute Ltd., East Grand Forks, Minnesota, United States
Desmopressin Acetate 0.2 mg Tablets, Fasting
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2009-09-11
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 48
- Registration Number
- NCT00835211
- Locations
- 🇨🇦
MDS Pharma Sercives, St. Laurent, Quebec, Canada
Fexofenadine Hydrochloride 180 mg Tablets Under Non-Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2009-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 24
- Registration Number
- NCT00835640
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2009-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 60
- Registration Number
- NCT00835276
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Divalproex Sodium Delayed-Release Tablets Under Non-Fasting Conditions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2009-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 24
- Registration Number
- NCT00834990
- Locations
- 🇺🇸
PRACS Institute Ltd., Fargo, North Dakota, United States
Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2009-08-18
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 48
- Registration Number
- NCT00834977
- Locations
- 🇨🇦
Anapharm Inc., Montreal, Quebec, Canada
🇨🇦SFBC Anapharm, Sainte-Foy, Quebec, Canada
Alendronate Sodium 70 mg Tablet Versus Fosamax® Under Fasting Conditions.
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2009-07-09
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 140
- Registration Number
- NCT00835406
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Pantoprazole Sodium 40 mg DR Tablets Under Non-Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2009-02-03
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 50
- Registration Number
- NCT00835393
- Locations
- 🇺🇸
Gateway Medical Research, Inc., St. Charles, Missouri, United States
🇺🇸Bioassay Laboratory, Inc., Houston, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath